Trichodysplasia of immunosuppression treated with oral valganciclovir

Journal of the American Academy of Dermatology

Volumn 60, Issue 1, 2009, Pages 169-172

  Holzer, Aton M ^a   Hughey, Lauren C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; IMIQUIMOD; TAZAROTENE; VALGANCICLOVIR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HAIR DISEASE; HAIR FOLLICLE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; IMMUNOSUPPRESSIVE TREATMENT; PAPULAR SKIN DISEASE; PRIORITY JOURNAL; SKIN MANIFESTATION; TREATMENT OUTCOME; TRICHODYSPLASIA OF IMMUNOSUPPRESSION;

ADMINISTRATION, ORAL; ADULT; FACIAL DERMATOSES; FEMALE; GANCICLOVIR; HUMANS; IMMUNOSUPPRESSION; SKIN DISEASES, PAPULOSQUAMOUS;

EID: 57649174157     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.07.051     Document Type: Article

References (25)

1. Sperling L.C. Follicular dystrophy of immunosuppression: reply. J Am Acad Dermatol 52 (2005) 540-541
2. Haycox C.L., Kim S., Fleckman P., Smith L.T., Piepkorn M., Sundberg J.P., et al. Trichodysplasia spinulosa-a newly described folliculocentric viral infection in an immunocompromised host. J Invest Dermatol Symp Proc 4 (1999) 268-271
3. Sperling L.C., Tomaszewski M.M., and Thomas D.A. Viral-associated trichodysplasia in patients who are immunocompromised. J Am Acad Dermatol 50 (2004) 318-322
4. Wyatt A.J., Sachs D.L., Shia J., Delgado R., and Busam K.J. Virus-associated trichodysplasia spinulosa. Am J Surg Pathol 29 (2005) 241-246
5. Heaphy Jr. M.R., Shamma H.N., Hickmann M., and White M.J. Cyclosporine-induced folliculodystrophy. J Am Acad Dermatol 50 (2004) 310-315
6. Daneshpazhooh M., and Asgari M. Follicular dystrophy of immunosuppression. J Am Acad Dermatol 52 (2005) 540
7. Chastain M.A., and Millikan L.E. Pilomatrix dysplasia in an immunosuppressed patient. J Am Acad Dermatol 43 (2000) 118-122
8. Izakovic J., Büchner S.A., Düggelin M., Guggenheim R., and Itin P.H. Haarartige Hyperkeratosen bei einem Nierentransplantierten Eine neue Cyclosporin-Nebenwirkung. [in German]. Hautarzt 46 (1995) 841-846
9. Sadler G.M., Halbert A.R., Smith N., and Rogers M. Trichodysplasia spinulosa associated with chemotherapy for acute lymphocytic leukaemia. Australas J Dermatol 48 (2007) 110-114
10. Lee J.S., Frederiksen P., and Kossard S. Progressive trichodysplasia spinulosa in a patient with chronic lymphocytic leukaemia in remission. Australas J Dermatol 49 (2008) 57-60
11. Osswald S.S., Kulick K.B., Tomaszewski M.M., and Sperling L.C. Viral-associated trichodysplasia in a patient with lymphoma: a case report and review. J Cutan Pathol 34 (2007) 721-725
12. Kroczynska B., Cutrone R., Bocchetta M., Yang H., Elmishad A.G., Vacek P., et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A 103 (2006) 14128-14133
13. Feng H., Shuda M., Chang Y., and Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 (2008) 1096-1100
14. Stolt A., Sasnauskas K., Koskela P., Lehtinen M., and Dillner J. Seroepidemiology of the human polyomaviruses. J Gen Virol 84 (2003) 1499-1504
15. MacConaill L., and Meyerson M. Adding pathogens by genomic subtraction. Nat Genet 40 (2008) 380-382
16. Josephson M.A., Williams J.W., Chandraker A., and Randhawa P.S. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis 8 (2006) 95-101
17. Segarra-Newnham M., and Vodolo K.M. Use of cidofovir in progressive multifocal leukoencephalopathy. Ann Pharmacother 35 (2001) 741-744
18. Saad E.R., Bresnahan B.A., Cohen E.P., Lu N., Orentas R.J., Vasudev B., et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 85 (2008) 850-854
19. Campbell R.M., Ney A., Gohh R., and Robinson-Bostom L. Spiny hyperkeratotic projections on the face and extremities of a kidney transplant recipient. Arch Dermatol 142 (2006) 1643-1648
20. Velupillai P., Garcea R.L., and Benjamin T.L. Polyoma virus-like particles elicit polarized cytokine responses in APCs from tumor-susceptible and -resistant mice. J Immunol 176 (2006) 1148-1153
21. Liu P.T., Krutzik S.R., Kim J., and Modlin R.L. Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol 174 (2005) 2467-2470
22. Holzer A.M., and Levis W.R. Antiviral immunotherapy: emerging approaches with relevance to cutaneous disease. Exp Rev Dermatol 2 (2007) 619-627
23. Humar A. Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis. Transplantation 82 (2006) S9-S14
24. Moens U., Van Ghelue M., Kristoffersen A.K., Johansen B., Rekvig O.P., Degré M., et al. Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoter. Virus Genes 23 (2001) 215-226
25. Matz B., Schlehofer J.R., and zur Hausen H. Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells. Virology 134 (1984) 328-337